Advertisement

What We’re Reading

“What We’re Reading” is a new feature on The Diabetes Self-Management Blog in which we highlight interesting posts on other diabetes blogs out there on the Web.

(What’s a blog, you ask? It’s short for “weblog,” and you’re reading one right now! Learn more about blogs from our earlier post on the topic.)

This week, we’d like to direct your attention to this post at diabetes.about.com about Wal-Mart’s new generic drug program, which will offer month-long supplies of 314 of the most commonly prescribed generic drugs for $4.00 apiece. This blog is written by Debra Manzella, a writer and practicing nurse. Read More “What We’re Reading”

Freedom at the End of a Leash

Some time after I started using an insulin pump, my endocrinologist (or “endo,” as I call him) asked me what I liked best about it.

“I can scrub the front porch whenever I want,” I responded after some thought.

It may sound like a strange answer, but it pretty much summed up the new flexibility I gained when I went from multiple daily injections to pumping. Read More “Freedom at the End of a Leash”

Public Warned About Fake OneTouch Test Strips

The U.S. Food and Drug Administration (FDA) is alerting people with diabetes to watch out for counterfeit blood glucose test strips intended for use with various models of LifeScan’s OneTouch blood glucose meters. While this announcement was originally made last Friday, October 13, additional lots of counterfeit test strips have been discovered over the past few days. Read More “Public Warned About Fake OneTouch Test Strips”

New Diabetes Drug Januvia Approved by FDA

The U.S. Food and Drug Administration (FDA) approved a new oral diabetes drug on Tuesday, October 17. The drug, sitagliptin (brand name Januvia), is manufactured by the pharmaceutical company Merck & Co., Inc., and is meant for use in people with Type 2 diabetes. Januvia is the first drug in a new class called dipeptidyl peptidase IV (or DPP-4) inhibitors to be approved. Read More “New Diabetes Drug Januvia Approved by FDA”

Accu-Chek Insulin Pump Hits U.S. Market

The Accu-Chek Spirit insulin pump, manufactured in Switzerland by Disetronic Medical Systems (a subsidiary of Roche Diagnostics Corp.), is now available in the United States. The pump “system,” which includes the Spirit insulin pump, a Palm PDA with Accu-Chek Pocket Compass software, a choice of one of three Accu-Chek blood glucose meters, and a choice of carrying case, will begin shipping on October 30. Read More “Accu-Chek Insulin Pump Hits U.S. Market”

Not Taking Prescribed Drugs Linked with Death in People with Diabetes

A recently published study of over 11,500 people with diabetes showed that a significant number—21%—do not take their blood-pressure–lowering, cholesterol-lowering, or blood-glucose–lowering pills regularly. Not surprisingly, the study found that these people have higher blood pressure, LDL (“bad”) cholesterol, and HbA1c levels (a measure of blood glucose over time). They also have a much higher chance of being hospitalized or dying than people who take their medicines regularly. Read More “Not Taking Prescribed Drugs Linked with Death in People with Diabetes”

3-D Life with Diabetes

Diabetes has been in my life indirectly since I was 10. (My little brother was diagnosed when he was 4 and I was 10.) Around the age of 16, I went to Shands Hospital in Gainesville, Florida, to see my brother at a diabetes camp, and some researchers there wanted to do blood work on siblings of people with diabetes. My older brother checked out fine, but they found something in my blood and response to glucose that, at the time, they called “markers.” Read More “3-D Life with Diabetes”

Get Diabetes-Friendly Recipes In Your Inbox

Sign up for Free

Stay Up To Date On News & Advice For Diabetes

Sign up for Free

Get On Track With Daily Lifestyle Tips

Sign up for Free

Save Your Favorites